Search

Author/Creator Stolina, M.

1. THU0397 Increased Bone Mass and Bone Strength by Sclerostin Antibody (Scl-Ab) is Maintained by a RANKL Inhibitor in OVX Rats with Established Osteopenia. (23rd January 2014)

Authors:
Ominsky, M.; Li, X.; Warmington, K.; Niu, Q.-T.; Asuncion, F.; Dwyer, D.; Grisanti, M.; Han, C.-Y.; Kostenuik, P.; Stolina, M.; Ke, H.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A299
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Sclerostin and DKK1 Inhibition Preserves and Augments Alveolar Bone Volume and Architecture in Rats with Alveolar Bone Loss. (August 2018)

Authors:
Liu, M.; Kurimoto, P.; Zhang, J.; Niu, Q.T.; Stolina, M.; Dechow, P.C.; Feng, J.Q.; Hesterman, J.; Silva, M.D.; Ominsky, M.S.; Richards, W.G.; Ke, H.; Kostenuik, P.J.
Journal:
Journal of dental research
Issue:
Volume 97:Number 9(2018)
Page Start:
1031
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗